Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Herrmann

Showing results (181-190 of 403) with videos related to

Pageof 41
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 13, 2019
Efficacy of Direct-acting Antivirals for Chronic Hepatitis C Virus Infection in People Who Inject Drugs or Receive Opioid Substitution Therapy: A Systematic Review and Meta-analysisChristiana Graf, Marcus M Mücke, Georg Dultz, et al.
Plos One|September 19, 2015
Serum Sphingolipid Variations Associate with Hepatic Decompensation and Survival in Patients with CirrhosisGeorgios Grammatikos, Nerea Ferreiròs, Oliver Waidmann, et al.
Journal of Hepatology|December 15, 2015
Lactic acidosis in patients with hepatitis C virus cirrhosis and combined ribavirin/sofosbuvir treatmentMartin-Walter Welker, Stefan Luhne, Christian M Lange, et al.
Frontiers in Pediatrics|December 3, 2019
Progressive Liver Disease in Patients With Ataxia TelangiectasiaHelena Donath, Sandra Woelke, Marius Theis, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|April 9, 2019
Intestinal failure-associated liver disease in patients with short bowel syndrome: Evaluation by transient elastographyViola Knop, Sophie-Charlott Neuberger, Sabine Marienfeld, et al.
Cellular and Molecular Gastroenterology and Hepatology|February 18, 2017
Oxidized Low-Density Lipoprotein Is a Novel Predictor of Interferon Responsiveness in Chronic Hepatitis C InfectionPhilipp Solbach, Sandra Westhaus, Maximilian Deest, et al.
Journal of Clinical Pharmacology|January 31, 2017
Conversion From Sirolimus to Everolimus in Long-Term Liver Graft RecipientsNina Weiler, Nigar Bilge, Sven Troetschler, et al.
European Journal of Gastroenterology & Hepatology|August 24, 2010
Serum lipids in European chronic HCV genotype 1 patients during and after treatment with pegylated interferon-α-2a and ribavirinChristian M Lange, Michael von Wagner, Jörg Bojunga, et al.
Acta Ophthalmologica|June 2, 2018
Comparison of standard and accelerated corneal cross-linking for the treatment of keratoconus: a meta-analysisMehdi Shajari, Carolin M Kolb, Bishr Agha, et al.
Pharmacogenetics and Genomics|February 25, 2011
Role of nucleoside transporters SLC28A2/3 and SLC29A1/2 genetics in ribavirin therapy: protection against anemia in patients with chronic hepatitis CAlexandra Doehring, Wolf Peter Hofmann, Christina Schlecker, et al.
Pageof 41

Showing results (181-190 of 403) with videos related to

Sort By:
Pageof 41
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 13, 2019
Efficacy of Direct-acting Antivirals for Chronic Hepatitis C Virus Infection in People Who Inject Drugs or Receive Opioid Substitution Therapy: A Systematic Review and Meta-analysisChristiana Graf, Marcus M Mücke, Georg Dultz, et al.
Plos One|September 19, 2015
Serum Sphingolipid Variations Associate with Hepatic Decompensation and Survival in Patients with CirrhosisGeorgios Grammatikos, Nerea Ferreiròs, Oliver Waidmann, et al.
Journal of Hepatology|December 15, 2015
Lactic acidosis in patients with hepatitis C virus cirrhosis and combined ribavirin/sofosbuvir treatmentMartin-Walter Welker, Stefan Luhne, Christian M Lange, et al.
Frontiers in Pediatrics|December 3, 2019
Progressive Liver Disease in Patients With Ataxia TelangiectasiaHelena Donath, Sandra Woelke, Marius Theis, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|April 9, 2019
Intestinal failure-associated liver disease in patients with short bowel syndrome: Evaluation by transient elastographyViola Knop, Sophie-Charlott Neuberger, Sabine Marienfeld, et al.
Cellular and Molecular Gastroenterology and Hepatology|February 18, 2017
Oxidized Low-Density Lipoprotein Is a Novel Predictor of Interferon Responsiveness in Chronic Hepatitis C InfectionPhilipp Solbach, Sandra Westhaus, Maximilian Deest, et al.
Journal of Clinical Pharmacology|January 31, 2017
Conversion From Sirolimus to Everolimus in Long-Term Liver Graft RecipientsNina Weiler, Nigar Bilge, Sven Troetschler, et al.
European Journal of Gastroenterology & Hepatology|August 24, 2010
Serum lipids in European chronic HCV genotype 1 patients during and after treatment with pegylated interferon-α-2a and ribavirinChristian M Lange, Michael von Wagner, Jörg Bojunga, et al.
Acta Ophthalmologica|June 2, 2018
Comparison of standard and accelerated corneal cross-linking for the treatment of keratoconus: a meta-analysisMehdi Shajari, Carolin M Kolb, Bishr Agha, et al.
Pharmacogenetics and Genomics|February 25, 2011
Role of nucleoside transporters SLC28A2/3 and SLC29A1/2 genetics in ribavirin therapy: protection against anemia in patients with chronic hepatitis CAlexandra Doehring, Wolf Peter Hofmann, Christina Schlecker, et al.
Pageof 41